187 related articles for article (PubMed ID: 30033503)
21. The human μ-opioid receptor gene polymorphism (A118G) is associated with head pain severity in a clinical cohort of female migraine with aura patients.
Menon S; Lea RA; Roy B; Hanna M; Wee S; Haupt LM; Griffiths LR
J Headache Pain; 2012 Oct; 13(7):513-9. PubMed ID: 22752568
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenetics of OPRM1.
Crist RC; Berrettini WH
Pharmacol Biochem Behav; 2014 Aug; 123():25-33. PubMed ID: 24201053
[TBL] [Abstract][Full Text] [Related]
23. Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study.
Beer B; Erb R; Pavlic M; Ulmer H; Giacomuzzi S; Riemer Y; Oberacher H
PLoS One; 2013; 8(9):e75359. PubMed ID: 24086514
[TBL] [Abstract][Full Text] [Related]
24. The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
Oueslati B; Moula O; Ghachem R
Pharmacogenomics; 2018 Jun; 19(8):741-747. PubMed ID: 29785888
[TBL] [Abstract][Full Text] [Related]
25. Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1).
Knapman A; Connor M
Br J Pharmacol; 2015 Jan; 172(2):349-63. PubMed ID: 24527749
[TBL] [Abstract][Full Text] [Related]
26. Associations among the opioid receptor gene (
Kim KM; Choi SW; Kim D; Lee J; Kim JW
J Behav Addict; 2019 Sep; 8(3):463-470. PubMed ID: 31553235
[TBL] [Abstract][Full Text] [Related]
27. Relapse-like behavior in a mouse model of the OPRM1 (mu-opioid receptor) A118G polymorphism: Examination with intravenous oxycodone self-administration.
Zhang Y; Collins D; Butelman ER; Blendy JA; Kreek MJ
Neuropharmacology; 2020 Dec; 181():108351. PubMed ID: 33031806
[TBL] [Abstract][Full Text] [Related]
28. OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis.
Haerian BS; Haerian MS
Pharmacogenomics; 2013 May; 14(7):813-24. PubMed ID: 23651028
[TBL] [Abstract][Full Text] [Related]
29. The A118G single-nucleotide polymorphism in OPRM1 is a risk factor for asthma severity.
Kawakami K; Miyasaka T; Nakamura Y; Metoki H; Miyata S; Sato M; Sora I; Yamauchi K; Kawakami K; Blendy JA; Kawano T; Shimokawa H; Takayanagi M; Ohno I; Takahashi T
Allergol Int; 2022 Jan; 71(1):55-65. PubMed ID: 34688555
[TBL] [Abstract][Full Text] [Related]
30. Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence.
Franke P; Wang T; Nöthen MM; Knapp M; Neidt H; Albrecht S; Jahnes E; Propping P; Maier W
Am J Med Genet; 2001 Jan; 105(1):114-9. PubMed ID: 11424981
[TBL] [Abstract][Full Text] [Related]
31. Opioid Addiction and Opioid Receptor Dimerization: Structural Modeling of the OPRD1 and OPRM1 Heterodimer and Its Signaling Pathways.
Wu B; Hand W; Alexov E
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638633
[TBL] [Abstract][Full Text] [Related]
32. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
[TBL] [Abstract][Full Text] [Related]
33. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans.
Fillingim RB; Kaplan L; Staud R; Ness TJ; Glover TL; Campbell CM; Mogil JS; Wallace MR
J Pain; 2005 Mar; 6(3):159-67. PubMed ID: 15772909
[TBL] [Abstract][Full Text] [Related]
34. Murine model of OPRM1 A118G alters oxycodone self-administration and locomotor activation, but not conditioned place preference.
Collins D; Zhang Y; Blendy J; Kreek MJ
Neuropharmacology; 2020 May; 167():107864. PubMed ID: 31778689
[TBL] [Abstract][Full Text] [Related]
35. The association between the OPRM1 A118G polymorphism and addiction in a Turkish population.
Türkan H; Karahalil B; Kadıoğlu E; Eren K; Gürol DT; Karakaya AE
Arh Hig Rada Toksikol; 2019 Jun; 70(2):97-103. PubMed ID: 31246565
[TBL] [Abstract][Full Text] [Related]
36. Neural Network Connectivity Following Opioid Dependence is Altered by a Common Genetic Variant in the µ-Opioid Receptor,
Xie Y; Brynildsen JK; Windisch K; Blendy JA
J Neurosci; 2024 Feb; 44(6):. PubMed ID: 38124015
[TBL] [Abstract][Full Text] [Related]
37. Polymorphism of Opioid Receptors μ1 in Highly Hypnotizable Subjects.
Presciuttini S; Curcio M; Sciarrino R; Scatena F; Jensen MP; Santarcangelo EL
Int J Clin Exp Hypn; 2018; 66(1):106-118. PubMed ID: 29319460
[TBL] [Abstract][Full Text] [Related]
38. OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models.
Mague SD; Blendy JA
Drug Alcohol Depend; 2010 May; 108(3):172-82. PubMed ID: 20074870
[TBL] [Abstract][Full Text] [Related]
39. Association of the
Sebold M; Garbusow M; Cerci D; Chen K; Sommer C; Huys QJ; Nebe S; Rapp M; Veer IM; Zimmermann US; Smolka MN; Walter H; Heinz A; Friedel E
J Psychopharmacol; 2021 May; 35(5):566-578. PubMed ID: 33726538
[TBL] [Abstract][Full Text] [Related]
40. Social hedonic capacity is associated with the A118G polymorphism of the mu-opioid receptor gene (OPRM1) in adult healthy volunteers and psychiatric patients.
Troisi A; Frazzetto G; Carola V; Di Lorenzo G; Coviello M; D'Amato FR; Moles A; Siracusano A; Gross C
Soc Neurosci; 2011; 6(1):88-97. PubMed ID: 20486014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
